1999•Zhongguo yaofangRequires access

Pharmacokinetics and Relative Bioavalability of Glipizide Tablet

Yuanda Zhou, Gaoqiong Yao

Open publisher page 0 citations

Abstract

OBJECTIVE:To determine the pharmacokinetics and bioavalability of glipizide tablet,and to compare Chongqing glipizide tablet with that produced in Hainan.METHODS:The drug concentrations in plasma were assayed by HPLC after administration of a single oral dose of 5mg Chongqing or Hainan glipizide to each of 12 healthy male volunteers in a randomized crossover study.RESUITS:The peak plasma levels averaged (267 26±64 35)ng/ml and (260 14±43 89)ng/ml,times to reach the peak level were (2 86±0 56)h and (2 92±0 7)h,and the areas under the drug concentration curves were (1 721 53±505 17)ng/(h·ml) and (1 714 00±266 29)ng/(h·ml) for Chongqing and Hainan glipizide,respectively.CONCLUSION:The result sh_owed that the two tablets were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To determine the pharmacokinetics and bioavalability of glipizide tablet,and to compare Chongqing glipizide tablet with that produced in Hainan.METHODS:The drug concentrations in plasma were assayed by HPLC after administration of a single oral dose of 5mg Chongqing or Hainan glipizide to each of 12 healthy male volunteers in a randomized crossover study.RESUITS:The peak plasma levels averaged (267 26±64 35)ng/ml and (260 14±43 89)ng/ml,times to reach the peak level were (2 86±0 56)h and (2 92±0 7)h,and the areas under the drug concentration curves were (1 721 53±505 17)ng/(h·ml) and (1 714 00±266 29)ng/(h·ml) for Chongqing and Hainan glipizide,respectively.CONCLUSION:The result sh_owed that the two tablets were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To determine the pharmacokinetics and bioavalability of glipizide tablet,and to compare Chongqing glipizide tablet with that produced in Hainan.METHODS:The drug concentrations in plasma were assayed by HPLC after administration of a single oral dose of 5mg Chongqing or Hainan glipizide to each of 12 healthy male volunteers in a randomized crossover study.RESUITS:The peak plasma levels averaged (267 26±64 35)ng/ml and (260 14±43 89)ng/ml,times to reach the peak level were (2 86±0 56)h and (2 92±0 7)h,and the areas under the drug concentration curves were (1 721 53±505 17)ng/(h·ml) and (1 714 00±266 29)ng/(h·ml) for Chongqing and Hainan glipizide,respectively.CONCLUSION:The result sh_owed that the two tablets were bioequivalent.

Key concepts: Glipizide, Bioequivalence, Pharmacokinetics, Crossover study, Pharmacology, Plasma concentration, Plasma levels, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Relative Bioavalability of Glipizide Tablet — Research Paper | ScholarLens